Fundamentally different from EBRT and traditional brain brachytherapy, GammaTile Therapy is a
surgically targeted radiation therapy (STaRT) that provides immediate, dose-intense treatment at
the completion of resection.
Patients with brain tumors face enormous challenges after diagnosis. Many of these challenges are
amplified by issues related to access to care. Studies suggest that patients with cancer who live
farther from radiation treatment centers have poorer clinical outcomes. Utilization of brain brachytherapy, localized radiation undertaken at the time and place of resection, could help lessen this access to care disparity.